Abstract

The first step in bacteriophage infection is recognition and binding to the host receptor, which is mediated by the phage receptor binding protein (RBP). Different RBPs can lead to differential host specificity. In many bacteriophages, such as Escherichia coli and Lactococcal phages, RBPs have been identified as the tail fiber or protruding baseplate proteins. However, the tail fiber-dependent host specificity in Pseudomonas aeruginosa phages has not been well studied. This study aimed to identify and investigate the binding specificity of the RBP of P. aeruginosa phages PaP1 and JG004. These two phages share high DNA sequence homology but exhibit different host specificities. A spontaneous mutant phage was isolated and exhibited broader host range compared with the parental phage JG004. Sequencing of its putative tail fiber and baseplate region indicated a single point mutation in ORF84 (a putative tail fiber gene), which resulted in the replacement of a positively charged lysine (K) by an uncharged asparagine (N). We further demonstrated that the replacement of the tail fiber gene (ORF69) of PaP1 with the corresponding gene from phage JG004 resulted in a recombinant phage that displayed altered host specificity. Our study revealed the tail fiber-dependent host specificity in P. aeruginosa phages and provided an effective tool for its alteration. These contributions may have potential value in phage therapy.

Highlights

  • Pseudomonas aeruginosa is an opportunistic pathogen that can cause a wide range of acute and chronic infections in cystic fibrosis, cancer, and burn patients, as well as in immunocompromised individuals [1,2,3,4,5,6]

  • Our data suggested that PaP1 and JG004 may encode different receptor-binding protein (RBP) that are responsible for differential host specificity

  • Given the paucity of novel antibiotics, phage therapy is proposed as a potential alternative treatment for P. aeruginosa infection

Read more

Summary

Introduction

Pseudomonas aeruginosa is an opportunistic pathogen that can cause a wide range of acute and chronic infections in cystic fibrosis, cancer, and burn patients, as well as in immunocompromised individuals [1,2,3,4,5,6]. P. aeruginosa remains a clinically important bacterial pathogen mainly because of its ability to develop resistance to antibiotics [7,8]. To fight this bacterium, alternative therapeutic strategies are explored, such as developing vaccines against P. aeruginosa and suppressing expression of virulence factor by inhibiting the quorum-sensing signals [9,10]. One of the promising alternative approaches to conventional antibiotics treatment is phage therapy [9,11,12,13]. The success of this treatment greatly depends on the host specificity of the phage. Specificity is often determined by the interaction between a phage receptor-binding protein (RBP) and a specific receptor on the surface of the host cell [14,15,16,17,18,19]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call